Meros drug and biologic delivery polymers
Meros Polymers Inc., AB, Canada
Meros drug delivery polymers provide enhanced solubility, stability and sustained release of pharmaceuticals for multiple routes of administration. Bio-compatible and biodegradable, the polymers self-assemble into drug-loaded micelles, which can be further processed by lyophilisation or spray-drying, suitable for formulation using conventional methods and facilities.
Primary Application Area: Pharmaceuticals & Personal Care
Technology Development Status: Prototype
Technology Readiness Level: TRL 6
FIGURES OF MERIT
Value Proposition: Meros technology combines highly effective solubilization, active targeting, sustained circulation by evading liver and kidney uptake, and local or systemic delivery. Our patented polymers accommodate a wide range of biological actives from small molecules to oligonucleotides and provide safe, highly targeted delivery to diseased cells, sparing healthy tissue.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: 28T
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: This technology was developed at the University of Alberta and has been extensively funded by Canadian federal granting agencies including the National Sciences and Engineering Research Council, the Canadian Institutes of Health Research and the former Alberta Heritage Foundation for Medical Research.
Primary Sources of Funding: Angel, Friends, Family, Federal Grant
Looking for: Both Funding and Development Partners